The Food and Drug Administration (FDA) conducted an inspection at PET KREWE, Inc. in New Orleans on March 20 to assess the monitoring of marketed animal drugs, feed, and devices, with information available on the FDA’s website.
The concluding report found that PET KREWE, Inc. was not required to implement any corrective measures for its management operations.
The FDA regularly inspects facilities nationwide to confirm that work environments and products comply with laws and regulations enforced to enhance public health. Results from these inspections are released to the public.
The FDA’s website notes that the agency primarily oversees the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information for this article comes from the U.S. Food and Drug Administration. The original data source is available here.
